These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7907828)

  • 1. [Calcium antagonists as modulators of multi-drug resistant tumor cells].
    Hamilton G; Theyer G; Baumgartner G
    Wien Med Wochenschr; 1993; 143(19-20):526-32. PubMed ID: 7907828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic circumvention of multidrug resistance.
    Ford JM; Hait WN
    Cytotechnology; 1993; 12(1-3):171-212. PubMed ID: 7765325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line.
    Abbaszadegan MR; Foley NE; Gleason-Guzman MC; Dalton WS
    Int J Cancer; 1996 May; 66(4):506-14. PubMed ID: 8635866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimers of N-alkylglycines are potent modulators of the multidrug resistance phenotype.
    Abad-Merin MJ; Cortés N; Masip I; Pérez-Payá E; Ferragut JA; Messeguer A; Ferrer-Montiel A
    J Pharmacol Exp Ther; 2005 Apr; 313(1):112-20. PubMed ID: 15644429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets in oncology: implications of the multidrug resistance gene.
    Lum BL; Gosland MP; Kaubisch S; Sikic BI
    Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
    Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance (MDR) genes in haematological malignancies.
    Nooter K; Sonneveld P
    Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
    Pasman PC; Schouten HC
    Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.
    Licht T; Fiebig HH; Bross KJ; Herrmann F; Berger DP; Shoemaker R; Mertelsmann R
    Int J Cancer; 1991 Oct; 49(4):630-7. PubMed ID: 1917165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
    Nielsen D; Skovsgaard T
    Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
    Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E
    Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma.
    Mickisch GH; Kössig J; Tschada RK; Keilhauer G; Schlick E; Alken PM
    Urol Int; 1991; 47(3):118-25. PubMed ID: 1685271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Canavanine modulates cellular growth, chemosensitivity and P-glycoprotein substrate accumulation in cultured human tumor cell lines.
    Worthen DR; Chien L; Tsuboi CP; Mu XY; Bartik MM; Crooks PA
    Cancer Lett; 1998 Oct; 132(1-2):229-39. PubMed ID: 10397478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.